《半日速報》恆指跌289點; 恆生科技指數跌97點 藥明生物跌逾6%
恆指半日收21,791點,跌289點或1.3%。恆生科技指數報4,490點,跌97點或2.1%。國指跌111點或1.5%,報7,497點。
活躍重磅股表現:
平安(02318.HK) 收56.85元,下跌2.7%;
阿里巴巴(09988.HK) 收105.5元,下跌2%;
港交所(00388.HK) 收353.4元,下跌1.4%;
騰訊(00700.HK) 收376.4元,下跌1.2%;
友邦(01299.HK) 收81.8元,下跌0.8%;
美團(03690.HK) 收161.7元,上升0.5%;
異動恆指及國指成份股:
藥明生物(02269.HK) 收64.35元,下跌6.2%;
百威亞太(01876.HK) 收19.2元,下跌5.9%;
海底撈(06862.HK) 收14.42元,下跌5.6%;
快手-W(01024.HK) 收71.8元,下跌4.6%;
新奧能源(02688.HK) 收106.4元,下跌4.6%;
恆隆地產(00101.HK) 收16.02元,下跌4.3%;
百度集團-SW(09888.HK) 收136.5元,下跌4.3%;
中國飛鶴(06186.HK) 收7.58元,下跌4.2%;
瑞聲(02018.HK) 收17.88元,下跌3.9%;
創科(00669.HK) 收111.6元,下跌3.7%;
金沙(01928.HK) 收18.12元,下跌3.6%;
京東集團(09618.HK) 收226.4元,下跌3.6%;
申洲(02313.HK) 收103.2元,下跌3.4%;
華潤啤酒(00291.HK) 收44.35元,下跌3.2%;
信達生物(01801.HK) 收28.65元,下跌3%;
異動綜合中小型股:
和鉑醫藥-B(02142.HK) 收4.55元,上升23%;
開拓藥業-B(09939.HK) 收24.9元,下跌13.7%;
天立教育(01773.HK) 收1.02元,上升12.1%;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.